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ABSTRACT
Brugada phenocopies (BrP) are clinical entities that present with an ECG pattern identical to either the type 1 or type 2 Brugada pattern 
without true congenital Brugada syndrome. This ECG pattern is associated with an identifiable condition and normalizes upon resolution 
or treatment of the underlying cause. We present a case of a 54-year-old man with extreme metabolic acidosis, hyperkalaemia and a 
Brugada type 1 ECG pattern in the setting of a suicidal methanol (MeOH) poisoning. Upon correction of these metabolic derangements with 
bicarbonate infusions and continuous veno-venous haemodiafiltration (CVVH), the Brugada type 1 ECG pattern normalized. Unfortunately, 
the patient developed signs of cerebral herniation followed by brain death and died on the first day of ICU admission.
LEARNING POINTS
• Brugada-like ECG patterns are described in several metabolic conditions such as extreme hyperglycaemia, glucose/insulin challenge, 
isolated hyperkalaemia or in association with hyponatraemia and acidosis. 
• Until now, there have been no published case reports of BrP in association with methanol intoxication. 
• Correction of hyperkalaemia and acidosis and specific therapy for methanol intoxication leads to a complete resolution of a Brugada 
type 1 ECG pattern.
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CASE DESCRIPTION
A 54-year-old man with a past history of hepatitis B and alcohol abuse in a Rehabilitation Centre was brought to our emergency department 
by his colleagues after being found in a comatose state. On admission, his Glasgow Coma Scale (GCS) score was 6 and physical examination 
disclosed Kussmaul’s respiration. A CT scan was normal. The patient was intubated for airway protection and was transferred to the 
intensive care unit (ICU). On ICU admission, his GCS score decreased to 4 with decerebrate posturing and generalized tonic-clonic seizures 
requiring 2 doses of intravenous diazepam. Auscultation of the lungs was normal. Blood pressure registered via a radial catheter was 60/30 
mmHg with poor peripheral perfusion. Transthoracic echocardiography showed hyperkinetic ventricles with normal diastolic and valvular 
function. The initial 12-lead ECG demonstrated an irregular rhythm with no clearly visible P waves and coved-type rectilinear-sloping ST-
segment elevation in leads V1 and V2 as well as an elevated J-point in leads V3 and V4 consistent with the Brugada type 1 pattern (Fig. 1). 
Laboratory results showed a severe metabolic acidosis with a HCO3- of 5.4 mmol/l and a pH of 6.60. The serum osmolality was 414 mOsm/
kg, Na+ 144 mmol/l, K+ 6.7 mmol/l, urea 7.6 mmol/l, glucose 16.4 mmol/l, Cl- 103 mmol/l and lactate 12.9 mmol/l. The anion and osmolal 
gaps were calculated:
Anion gap: ([Na] + [K]) – ([Cl] + [HCO3]) = (144 + 6.7) – (103 + 5.4) = 42.3 mmol/l (normal value: 14±4 mmol/l)
Osmolal gap: Serum osmol – (1.86 (Na + K) + glucose + urea + 10) = 414 – 314.3 = 99.7 mOsm/kg (normal value: <10 mOsm/kg)
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Due to the suspicious circumstances and severe metabolic acidosis with extremely enhanced anion and osmolal gaps, methanol (MeOH) 
or ethylene glycol intoxication was suspected and a serum toxicologic screen was ordered. Correction of acidosis was initiated with 
bicarbonate infusions and shortly after with continuous veno-venous haemodiafiltration (CVVH) and therapy with intravenous thiamine, 
pyridoxine, folic acid and ethanol was instituted. Fluid resuscitation and a noradrenaline infusion improved haemodynamic parameters. 
After amelioration of metabolic acidosis (pH 6.97, HCO
3
- 11 mmol/l) and correction of hyperkalaemia in 6 hours, the 12-lead ECG showed 
resolution of the Brugada type 1 pattern (Fig. 2). Unfortunately, the patient remained in a coma state evolving to brain death and died on the 
first day of the ICU stay. The serum MeOH concentration was 298.2 mg/dl (NV <5 mg/dl). 
Figure 1. ECG on ICU admission. Irregular rhythm with no clearly visible P waves, type 1 
Brugada pattern with a “coved” ST-segment elevation in the right precordial leads (arrows) 
Figure 2. ECG after correction of hyperkalaemia and therapy for methanol intoxication 6 
hours later. Sinus rhythm, a convex ST-segment elevation of ≤0.1 mV in the right precordial 
leads mimicking a type 2 Brugada pattern (arrows). β-angle <58º (Chevallier angle), not 
fulfilling criteria for type 2 Brugada pattern (in blue).
DISCUSSION
“Brugada phenocopy” was a term initially proposed by Riera et al.[1] to describe an acquired Brugada-like ECG pattern in the setting of 
propofol infusion syndrome. The term “phenocopy” describes “an environmental condition that imitates one produced by a gene”. Brugada 
phenocopies (BrP) are clinical entities that present with identical ECG patterns to those of true Brugada syndrome (BrS); the ECG pattern 
normalizes once the underlying condition is treated or resolves. BrP constitute a group of heterogeneous conditions that have been 
characterized into 6 distinct aetiological categories: metabolic conditions, mechanical compression, ischaemia, myocardial and pericardial 
disease, ECG modulation and miscellaneous causes[2]. Seven criteria are used to differentiate BrP from BrS, of which 5 are mandatory for 
BrP diagnosis[3]. 
Metabolic abnormalities are among the underlying conditions of BrP in normal subjects. Several reports exist in the literature of BrP occurring 
in relation to various metabolic derangements such as glucose[4] and glucose/insulin challenge[5], isolated hyperkalaemia[6] or in association 
with other metabolic disturbances including extreme hyperglycaemia, hyponatraemia and acidosis[7]. The physiopathological mechanisms 
by which these extreme electrolyte imbalances induce BrP are not well known. Hyperkalaemia may reproduce BrP by decreasing the resting 
membrane potential causing an indirect inactivation of Na+ channels[8].  
Although ethanol is reported in the literature as a possible trigger for BrS[9], ventricular fibrillation in BrS or BrP due to its inhibitory effect 
on cardiac single sodium channel gating[10], we have not found any medical evidence linking MeOH intoxication with BrP. Given that ethanol 
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and MeOH share similarities in physicochemical structure, it could be speculated that the latter could trigger a Brugada phenocopy by 
mechanisms similar to ethanol. In our patient, correction of hyperkalaemia, amelioration of metabolic acidosis and treatment of MeOH 
intoxication led to normalization of the Brugada ECG pattern allowing us to infer a direct association between these “environmental factors” 
and the pathological ECG tracing. Unfortunately, due to the early death of the patient, we could not perform either provocative or genetic 
testing.  
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